Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma

Wendi Bao; Kendall L. Buchanan; Loretta S. Davis

doi:10.1002/ccr3.4367

Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma

Wendi Bao, Kendall L. Buchanan, Loretta S. Davis

Dermatology

Research output: Contribution to journal › Article › peer-review

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a rare but aggressive lymphoma that commonly presents with skin involvement, often morphologically similar to viral or drug-induced morbilliform eruptions. Morbilliform rashes with systemic symptoms of unclear etiology mandate a thorough workup; empiric corticosteroid therapy is best avoided and may delay diagnosis of underlying malignancy such as AITL.

Original language	English (US)
Article number	e04367
Journal	Clinical Case Reports
Volume	9
Issue number	6
DOIs	https://doi.org/10.1002/ccr3.4367
State	Published - Jun 2021

Keywords

T-cell lymphoma
dermatology
morbilliform rash
oncology

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/ccr3.4367

Cite this

@article{5eae3c5315da4aa991b3de09db7c81c6,

title = "Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma",

abstract = "Angioimmunoblastic T-cell lymphoma (AITL) is a rare but aggressive lymphoma that commonly presents with skin involvement, often morphologically similar to viral or drug-induced morbilliform eruptions. Morbilliform rashes with systemic symptoms of unclear etiology mandate a thorough workup; empiric corticosteroid therapy is best avoided and may delay diagnosis of underlying malignancy such as AITL.",

keywords = "T-cell lymphoma, dermatology, morbilliform rash, oncology",

author = "Wendi Bao and Buchanan, {Kendall L.} and Davis, {Loretta S.}",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",

year = "2021",

month = jun,

doi = "10.1002/ccr3.4367",

language = "English (US)",

volume = "9",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Not your typical morbilliform rash

T2 - Angioimmunoblastic T-cell lymphoma

AU - Bao, Wendi

AU - Buchanan, Kendall L.

AU - Davis, Loretta S.

PY - 2021/6

Y1 - 2021/6

N2 - Angioimmunoblastic T-cell lymphoma (AITL) is a rare but aggressive lymphoma that commonly presents with skin involvement, often morphologically similar to viral or drug-induced morbilliform eruptions. Morbilliform rashes with systemic symptoms of unclear etiology mandate a thorough workup; empiric corticosteroid therapy is best avoided and may delay diagnosis of underlying malignancy such as AITL.

AB - Angioimmunoblastic T-cell lymphoma (AITL) is a rare but aggressive lymphoma that commonly presents with skin involvement, often morphologically similar to viral or drug-induced morbilliform eruptions. Morbilliform rashes with systemic symptoms of unclear etiology mandate a thorough workup; empiric corticosteroid therapy is best avoided and may delay diagnosis of underlying malignancy such as AITL.

KW - T-cell lymphoma

KW - dermatology

KW - morbilliform rash

KW - oncology

UR - http://www.scopus.com/inward/record.url?scp=85112714378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112714378&partnerID=8YFLogxK

U2 - 10.1002/ccr3.4367

DO - 10.1002/ccr3.4367

M3 - Article

AN - SCOPUS:85112714378

SN - 2050-0904

VL - 9

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 6

M1 - e04367

ER -

Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this